ConductScience.org, home

Paper39693187

Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China.

Yang J and 14 others. Hum Vaccin Immunother, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China. Papers, record 39693187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39693187

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China.
PubMed
Journal
Hum Vaccin Immunother
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.45, provisional
iCite
Revised in PubMed
2026-07-20
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang JJunting
2Welby SSarah
3Liu ZZhike
4Deng SSiwei
5Liu GGuangxu
6Meng RRuogu
7Yang YYu
8Sun YYixin
9He YYunkun
10Jiang NNing
11Wu ZZhenhua
12Liu KKeruo
13Rosillon DDominique
14Cohet CCatherine
15Zhan SSiyan

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Papillomavirus VaccinesMajor topic
Electronic Health RecordsMajor topic
Papillomavirus InfectionsMajor topic
Human papillomavirus 18Major topic
Humans
Female
China
Adolescent
Adult
Young Adult
Cohort Studies
Child
Pregnancy
Middle Aged
Human papillomavirus 16
Adjuvants, Immunologic
Pregnancy Outcome
Vaccination
Incidence

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122262597Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research.Pharmacoepidemiol Drug Saf2012https://conductscience.org/library/papers/22262597PubMed
219586656
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Lancet2009https://conductscience.org/library/papers/19586656PubMed
330229993Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.Br J Clin Pharmacol2018https://conductscience.org/library/papers/30229993PubMed
423391600Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines.Vaccine2013https://conductscience.org/library/papers/23391600PubMed
528984053Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.Cancer Med2017https://conductscience.org/library/papers/28984053PubMed
629440217Using big data to improve cardiovascular care and outcomes in China: a protocol for the CHinese Electronic health Records Research in Yinzhou (CHERRY) Study.BMJ Open2018https://conductscience.org/library/papers/29440217PubMed
729854103Applying the Concept of Nutrient-Profiling to Promote Healthy Eating and Raise Individuals' Awareness of the Nutritional Quality of their Food.AMIA Annu Symp Proc2017https://conductscience.org/library/papers/29854103PubMed
833271093Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.Lancet Oncol2020https://conductscience.org/library/papers/33271093PubMed
935568189COVID-19 vaccination in pregnancy.Am J Obstet Gynecol2022https://conductscience.org/library/papers/35568189PubMed
1024644063Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme.Pharmacoepidemiol Drug Saf2014https://conductscience.org/library/papers/24644063PubMed
1134754439Influence of doctors' perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China.Clin Kidney J2021https://conductscience.org/library/papers/34754439PubMed
1229477308Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.Vaccine2018https://conductscience.org/library/papers/29477308PubMed
1337228132A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case.Pharmacoepidemiol Drug Saf2023https://conductscience.org/library/papers/37228132PubMed
1429030998Hidden biases in observational epidemiology: the case of unmeasured confounding.BJOG2018https://conductscience.org/library/papers/29030998PubMed
1536730318COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.PLoS One2023https://conductscience.org/library/papers/36730318PubMed
1619450645WHO position on HPV vaccines.Vaccine2009https://conductscience.org/library/papers/19450645PubMed
1736271052Thiazolidinedione use and risk of Parkinson's disease in patients with type 2 diabetes mellitus.NPJ Parkinsons Dis2022https://conductscience.org/library/papers/36271052PubMed
1831876615Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.Pediatr Infect Dis J2020https://conductscience.org/library/papers/31876615PubMed
1931305011Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.Cancer Med2019https://conductscience.org/library/papers/31305011PubMed
2025424785Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years.Hum Vaccin Immunother2014https://conductscience.org/library/papers/25424785PubMed

See all 29 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42348585
Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort study.
Hum Vaccin Immunother2026https://conductscience.org/library/papers/42348585PubMed
40276516Development and validation of identification algorithms for five autoimmune diseases using electronic health records: a retrospective cohort study in China.Front Immunol2025https://conductscience.org/library/papers/40276516PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39693187

GET https://conductscience.org/api/papers/v1/39693187/references?page=2